NR3C1 and leukemia: By a 3′-terminal stem-loop structure that mimics GREs and blocks GR/SR DBD, GAS5 represents a potent riborepressor of GR signaling [29,30], and thus targeting of GAS5 in GC-treated leukemias could provide further insights on GC resistance as well as novel molecular markers to support modern precision medicine.